Cargando…
The challenge of developing pain medications for children: therapeutic needs and future perspectives
It is broadly accepted that children of all age groups including (preterm) neonates and young infants can perceive pain and that there is an absolute need to treat their pain safely and effectively. The approved treatment options for children, particularly (preterm) neonates and young infants, are v...
Autores principales: | Eerdekens, Mariëlle, Beuter, Christoph, Lefeber, Claudia, van den Anker, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536714/ https://www.ncbi.nlm.nih.gov/pubmed/31213880 http://dx.doi.org/10.2147/JPR.S195788 |
Ejemplares similares
-
Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population
por: Watson, Estelle, et al.
Publicado: (2019) -
Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years
por: Eissa, Ayman, et al.
Publicado: (2021) -
COVID-19 therapeutics: Challenges and directions for the future
por: Robinson, Philip C., et al.
Publicado: (2022) -
Age-friendly cities: challenges for future research
por: Noordzij, J Mark, et al.
Publicado: (2019) -
Efficacy and safety of multiple doses of tapentadol oral solution in the treatment of moderate to severe acute pain in children aged 2 to <18 years – a randomized, double-blind, placebo-controlled trial
por: Beuter, Christoph, et al.
Publicado: (2019)